GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $1B invested in Genomic Health, Inc. in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
134
Holding in Top 10
1
Calls
$4.14M
Puts
–
Top Buyers
| 1 | +$44.2M | |
| 2 | +$7M | |
| 3 | +$6.23M | |
| 4 |
Renaissance Technologies
New York
|
+$5.34M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.08M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.37M | |
| 3 | -$4.51M | |
| 4 |
First Manhattan
New York
|
-$3.79M |
| 5 |
CPA
Cowen Prime Advisors
New York
|
-$3.38M |